Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Are risk evaluation and mitigation strategies associated with less off-label use of medications? The case of immune thrombocytopenia.
Clinical pharmacology and therapeutics·2015
Clinical and regulatory features of drugs not initially approved by the FDA.
Clinical pharmacology and therapeutics·2013
Defining "innovativeness" in drug development: a systematic review.
Clinical pharmacology and therapeutics·2013
Defining the epidemiology of bisphosphonate-associated osteonecrosis of the jaw: prior work and current challenges.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2012
Refilling and switching of antiepileptic drugs and seizure-related events.
Clinical pharmacology and therapeutics·2010
Understanding non-medical prescribers' antimicrobial prescribing and stewardship competency: A scoping review.
Research in social & administrative pharmacy : RSAP·2026
False Friends in Fluorescence - Simple HPLC Evaluation of False Positive Fragment Hits in a DiFMUP Assay for Protein Tyrosine Phosphatase 1B.
Drug design, development and therapy·2026
Rebalancing innovation, affordability, and access for orphan drugs in the European Union.
The Lancet regional health. Europe·2026
Clinical and Economic Burden of Diseases with Accelerated Approval Therapies: Evidence of Unmet Patient Need.
Therapeutic innovation & regulatory science·2026